ArticleAmerican journal of cancer research2026
Targeting PRMT5 with indole-based arylsulfonylhydrazides: a novel epigenetic strategy for the treatment of acute and chronic leukemia.
Jingyi Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.